A polymerase chain reaction (PCR)-based detection assay that specifically detected Ehrlichia canis in dogs with acute infections was developed. A region of the 16S ribosomal RNA gene of E. canis was targeted for PCR amplification and chemiluminescent hybridization (CH) with a complementary internal 287-base pair (bp) oligonucleotide probe. The CH improved the PCR assay sensitivity 1,000-fold as compared with visualization on ethidium bromide-stained agarose gels. The PCR assay with CH (PCRKH) detected as little as 30 fg of E. canis genomic DNA, the equivalent of approximately 150 E. canis organisms. The 495-bp product defined by the specific primers was not detected when genomic DNA from E. platys, E. chaffeensis, E. risticii, and E. equi were used in the PCR/CH assay. The PCR/CH assay was tested with unfractionated blood samples collected from 9 dogs experimentally infected with E. canis. The PCR/CH assay had greater detection sensitivity than did cell culture isolation (CCI) from infected blood. PCR/CH detected E. canis 7 days prior to CCI in 4 of 6 experimentally infected dogs. The results obtained with the PCR/CH assay otherwise consistently matched the results obtained by CCI. This PCR/CH assay is a rapid, sensitive, and specific method for E. canis detection with sensitivity comparable to or exceeding that of CCI. A diagnosis of E. canis using this PCR/CH assay can be made in 2 days as compared with 14 weeks for CCI. The PCR/CH assay appears to be an acceptable alternative or complement to current diagnostic techniques.
Canine ehrlichiosis is a tick-borne disease caused by an obligate intracellular parasite, Ehrlichia canis, which resides and replicates within mononuclear cells. 7 The organism has a global distribution, including the United States, northern and southern African countries, Europe, Southeast Asia, and India. 1, 2, [5] [6] [7] The association of E. canis with hemorrhagic disease in dogs was first described in 1969. 8 Diagnosis of canine in the early stage of infection is important to ensure early treatment and a good prognosis. 7 Dogs in the acute phase of the disease demonstrate dramatic improvement in hematologic and clinical responses 24-48 hours after therapy. 7 However, dogs in the chronic stage of the disease have a poor prognosis and may not improve following treatment. 7, 11 Currently, definitive diagnosis of canine ehrlichiosis is based on hematologic, biochemical, and serologic findings. 7 However, the most clinically reliable method for diagnosis of canine ehrlichiosis is by serologic techniques such as immunofluorescent antibody test (IFA) and plate latex agglutination that detect E. canis serum antibodies. 7 However, serologic tests have several disadvantages: IgM and IgG antibodies are not detectable until at least 1-3 weeks postinfection, and cross-reactions occur between Ehrlichia species. Both of these factors can sometimes make a differential diagnosis difficult. Alternatively, the use of cell culture isolation (CCI) to detect E. canis in blood from infected dogs is both sensitive and specific . 9, 10 However, CCI requires 1-4 weeks to obtain results, thus limiting its usefulness as a rapid diagnostic tool.
A polymerase chain reaction (PCR)-based assay for E. canis detection has been reported and its sensitivity compared with that of CCI. 9 In that report, CCI was more sensitive than the PCR assay. Nevertheless, the identity of the PCR-amplified product and species specificity of the previous PCR assay was not adequately confirmed. In the present investigation, we report a rapid, sensitive, and specific PCR/chemiluminescent hybridization (CH) assay that is more sensitive than CCI. This PCR/CH assay will be advantageous for diagnosis, early treatment, and epidemiologic investigations of ehrlichiosis among susceptible canine populations. were housed in individual pens at Louisiana State University
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Laboratory Animal Resources. Prior to the study, the dogs 441 Clinical and hematologic parameters were also normal. Dogs had received routine veterinary medical care prior to this study.
Inoculum. Ehrlichia canis (Louisiana isolate) was propagated in canine-origin cells.
b The cells have not been completely characterized but are phenotypically and functionally similar to macrophages and originated from a primary culture of canine bone marrow cells. The cells were propagated in Fischer's medium c with 20% horse serum, d hydrocortisone e (20 µg/ml), and 2 mM L-glutamine c without antibiotics at 37 C in tightly capped flasks. The inoculum was prepared from a single pool of canine-origin cells highly infected (> 90%, by IFA) with E. canis. The infectivity of the inoculum was assessed by the following method. Ten-fold serial dilutions (through 10 6 ) of fresh and liquid-nitrogen-frozen inoculum (0.5 ml) were added to 1-day-old confluent cultures of canineorigin cells in a 25cm 2 (Table 1 ). All doses of inoculum were adjusted to a final volume of 2 ml in phosphate-buffered saline (PBS) and administered subcutaneously on the dorsal midline between the scapulae. The following parameters were measured at 0, 7, 14, 21, 28, and 35 days postinoculation (dpi): platelet concentration, serum IgG anti-E. canis antibodies, presence of E. canis in blood with CCI using canine-origin cells, and detection by PCR/CH. Dogs that developed ehrlichial infections during the study were treated with 10 mg/kg doxycycline for 10 days at the conclusion of the study.
Immunofluorescent antibody test. An IFA procedure was used to monitor serum IgG antibody responses and CCI of E. canis from infected canine buffy coats. Serum antibody responses were monitored using antigen-coated 10-well Teflon-coated slides f prepared from E. canis-infected canineorigin cells. The antigen slides were prepared using a washed cell suspension of 1 x 10 5 /ml of E. canis-infected canineorigin cells in PBS (50% infected, by IFA). The slide wells were first coated with 4 µl of 5% bovine serum albumin and allowed to dry at 37 C for 2 hr. The infected cell suspension was placed into the wells (11 µl) and allowed to dry at 37 C overnight. The slides were fixed in cold acetone for 10 min, allowed to dry, then stored at -20 C for future use. Each serum sample was diluted 1:40 and 180 in PBS, placed in the wells of the antigen-coated slides (10 µl), and incubated for 30 min. After 3 successive 5-min washes in PBS, a fluorescein-conjugated goat anti-dog IgG (whole molecule) g diluted 1:80 was added (10 µl) to the wells and incubated for 30 min. All incubations were performed in a 37 C humidified incubator. Slides were washed 3 times in PBS, coverslipped, and viewed with an epifluorescence microscope with 12 x eyepieces and a 40 x planapochromatic objective.
Cell culture isolation. Five milliliters of whole blood collected in ethylenediaminetetraacetic acid (EDTA) was centrifuged at 500 x g for 10 min. The buffy coat was harvested and overlaid directly onto 1-day-old semiconfluent monolayers of canine-origin cells in a 25-cm 2 flask containing culture medium. The culture medium was replaced 24 hr after inoculation and weekly (for 5 wk) thereafter. Cell smears from cultures inoculated with canine buffy coats were prepared with a cytocentrifuge, h fixed in cold acetone for 10 min, and stained with a positive antiserum (1:320, by IFA, from E. canis-infected dog) using the IFA procedure. Cultures were examined every 7 days prior to medium replacement. j and from a dog infected with E. platys (isolated from a dog submitted to the LSU-SVM clinic). Ehrlichia-infected canine-origin cell cultures and whole blood were frozen and thawed once. The cells and whole blood were passed through a Sorvall French press at 6,000 psi with a flow rate of 15 ml/min. The pressed material was centrifuged at 2,920 x g for 10 min to remove cellular debris. The supernatant was collected and centrifuged at 14,500 x g for 20 min to pellet the Ehrlichia organisms. The organisms were washed 2 times by resuspending in PBS and pelleting as described above. The washed pellet was resuspended in PBS to achieve a final protein concentration of 2 mg/ml.
Nucleic acid extraction. Nucleic acid from purified Ehrlichia (E. canis, E. equi, E. chaffeensis, E. platys) was extracted by resuspending the pelleted organisms in 600 µl of 10 mM Tris-HCl buffer (pH 8.0) with 1% sodium dodecyl sulfate (SDS) e (w/v) and 100 ng/ml of proteinase K e Blood samples were processed as follows. Two hundred microliters of whole blood collected in EDTA was diluted with 400 µl of 10 mM Tris-HC1 (pH 8), 1% SDS, and 100 ng/ml of proteinase K. This mixture was incubated at 50 C for 1 hr and then extracted with 600 µl of Tris (pH 8)-saturated phenol-chloroform isoamyl alcohol (25:24:1). The aqueous layer was removed and reextracted with the phenol-chloroform mixture. The nucleic acid was washed (3 times) and concentrated using a microconcentrator.
k Nucleic acid was washed by adding 450 µl of double distilled H 2 O and centrifuging at 14,000 x g until < 50 µl remained in the microconcentrator. After the final wash, the volume of all samples was adjusted to 50 µl.
Primer selection. Primers (20 oligomers) for detection of E. canis were designed from a variable region of the 16S ribosomal RNA (rRNA) gene sequence of E. canis, which is A hot start PCR with a 2-stage, 2-step thermal cycling procedure was utilized. The first stage consisted of 3 cycles of denaturation at 95 C for 1 min followed by annealing and extension at 50 C for 1 min. The second stage included 40 cycles of denaturation at 92 C for 1 min and then annealing and extension at 50 C for 1 min. PCR products and a molecular weight marker (100-bp DNA ladder c ) were electrophoresed through a 1.5% agarose gel stained with ethidium bromide and photographed with UV illumination. The identity of the PCR product was confirmed by CH. The same PCR amplification protocol was utilized to synthesize the internal probe, except 1 ng of genomic E. canis DNA was the starting template.
Chemiluminescent hybridization. PCR products were confirmed and detection sensitivity was improved by utilizing a sensitive CH procedure.
o PCR products were transferred from agarose gels to nylon membrane p using a vacuum blotting apparatus q according to the manufacturer's protocol. PCR products were denatured in 1.5 M NaCl and 0.5 M NaOH for 4 min and neutralized in 1.0 M Tris-HCl and 2.0 M NaCl (pH 5.0) for 4 min. The PCR products were transferred in 5 x standard saline citrate (SSC) at 40 mbar pressure for 90 min. Blotted PCR products were crosslinked with ultraviolet light and prehybridized in 6 ml of hybridization buffer containing 0.5 M NaCl at 42 C for 30 min in a hybridization oven.
r A PCR-generated DNA probe derived from an internal sequence of the PCR product was synthesized and then purified using a DNA purification protocol.
s The probe was quantitated spectrophotometrically at A 260 . For each hybridization, 150 ng of the probe was denatured and covalently linked to horseradish peroxidase with glutaraldehyde.
o The probe was added to the hybridization buffer and incubated for 24 hr at 42 C. After hybridization, the membrane was removed and washed twice for 20 min in a wash buffer containing 6.0 M urea, 0.4% SDS, and 0.2 x SSC at 42 C. The membrane was washed twice for 5 min each in 2 x SSC at room temperature. An appropriate volume of detection reagent was then added to the membrane surface for 1 min. Excess detection reagent was drained, and the membrane was wrapped in plastic wrap and then exposed to X-ray film t for 2 hr. PCR sensitivity. Sensitivity of the test was determined using 10-fold serial dilutions of DNA extracted from purified E. canis (Fig. 1) . The quantity of genomic DNA used for amplification was estimated spectrophotometrically at A 260 and A 280 . The minimum sensitivity was determined by 10-fold serial dilutions of a known starting quantity of E. canis PCR specificity. Specificity was determined using Ehrlichia chaeensis, E. platys, and E. equi genomic DNA extracted from crude purifications of each organism (1 ng of genomic DNA, the equivalent of approximately 5 million Ehrlichia) and total genomic DNA extracted from P388 mouse macrophages infected with E. risticii (1 µg) .
Results
Detection of E. canis 16S rRNA gene with PCR was optimized with genomic DNA extracted from purified E. canis. The sensitivity of this protocol was determined to be 300 pg with ethidium bromide-stained agarose gels, the equivalent of approximately 1.5 x 106 E. canis organisms (Fig. 1) . The CH increased the detection sensitivity to 30 fg, the equivalent of approximately 150 E. canis organisms (Fig. 2) .
Using 1 ng of genomic DNA from purified E. chaffeensis, E. platys, and E. canis and 1 µg of total DNA from E. risticii-infected P388 mouse macrophages, E. canis was the only genomic target that amplified the specific 495-bp product (Fig. 2) .
Unfractionated blood samples collected from dogs experimentally infected with E. canis were tested by CCI and PCR/CH ( Table 1 ). The PCR/CH assay detected E. canis 1 week prior to detection by CCI in 4 of 6 dogs that had E. canis infections. Three dogs inoculated with E. canis did not exhibit thrombocytopenia nor was E. canis isolated by PCR/CH or CCI. All dogs in group 1 (8 x 10 2 TCID) developed thrombocytopenia. Ehrlichia canis serum IgG antibodies were also detected in these dogs 21 dpi and increased in titer through 35 dpi. Two dogs in group 1 were PCR/CH positive by 7 dpi, and 1 was positive by CCI and PCR/ CH 14 dpi (Table 1, Fig. 3 ). The dogs remained positive by both detection methods through 35 dpi. Two dogs Ehrichia species. Top. Genomic DNA (1 ng each) from purified Ehrlichia (E. platys, E. equi, E. chaffeensis, and E. canis, lanes 1-4 and 6, respectively) and E. risticii (1 µg DNA from E. canis-infected P388 cells, lane 5) as targets. Amplified products were electrophoresed through a 1.5% agarose gel and visualized with ethidium bromide staining. The amplified PCR product corresponding to the E. canis target is visualized. Bottom. Southern blot hybridization of the corresponding agarose gel. PCR product corresponding to E. canis is detected.
in group 2 (4 x 10 2 TCID) developed thrombocytopenia. These dogs were also positive for E. canis by PCR/CH and developed serum IgG antibodies 28 dpi (Table 1 , Fig. 4) . Ehrlichia canis was isolated from these dogs 35 dpi by CCI. One dog in group 2 remained negative for E. canis by both PCR/CH and CCI and did not develop thrombocytopenia. One dog in group 3 (2 x 10 2 TCID) developed thrombocytopenia, and E. canis was isolated using CCI and PCR/CH 21 dpi (Table 1) . Ehrlichia canis serum IgG antibodies were also detected at 28 dpi, and an increased titer was observed at 35 dpi. Two dogs in group 3 remained clinically normal, and E. canis was not isolated by CCI or PCR/CH. Dogs in all goups were negative by PCR/ CH and CCI on day 0. 
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Discussion
The PCR assay described in this report can be a rapid and sensitive alternative or a complement to existing diagnostic tests for detection of E. canis infections. The shortcomings of currently used diagnostic techniques such as inadequate sensitivity and difficulties with differential diagnosis are overcome by PCR technology. The PCR assay has other advantages over current diagnostic techniques; it is rapid and reliable and allows specific detection of the infectious agent. Difficulties also exist in distinguishing seropositive chronic carriers of E. canis from uninfected seropositive dogs. PCR/CH may provide a reliable method to distinguish between these groups. In this report, detection of experimentally induced acute E. canis infections was made with the PCR/CH assay. However, further investigation with PCR/CH is necessary to determine if chronic carriers can be detected with this assay.
The sensitivity of the PCR assay by visualization of the 494-bp PCR products in ethidium bromide-stained agarose gels was 320 pg of E. canis genomic DNA. The sensitivity of this PCR protocol was increased using CH to 30 fg, the equivalent of approximately 150 organisms. The genome size of E. canis is not known. Therefore, the genome size of Escherichia coli was used to estimate the number of organisms represented by the spectrophotometric measurement of extracted nucleic acid. This PCR/CH assay appears to be more sensitive than the previously reported PCR assay. 10 However, a direct comparison cannot be made because the sensitivity study in a previous report utilized DNA from infected cell culture cells, not genomic DNA from purified E. canis. In our investigation, PCR products were often not visualized in ethidium bromide-stained agarose gels but were detected with CH. The increased sensitivity afforded by the CH allowed low-level detection of E. canis from a small volume of blood. Thus, the procedure was simplified and the time required to obtain results was reduced. Losses of nucleic acid that typically occur during the phenol extraction were not accounted for in the sensitivity study. For this reason, the sensitivity of the PCR/CH assay as applied to clinical samples may be reduced. Further testing of blood samples containing known amounts of E. canis would be necessary to establish the sensitivity of the assay as it specifically relates to clinical specimens.
The specificity of this PCR assay is based upon amplification of the 495bp product using E. canis DNA with specific primers EC1 and EC2. To confirm the identity of the PCR product and to increase the sensitivity of the assay, a 287-bp internal probe was used in a CH reaction. The internal probe hybridizes with a complementary region within the 495bp PCR prod- 14: positive uct. The specificity of the PCR/CH assay was tested using purified genomic DNA (1 ng) from other Ehrlichia species (E. equi, E. chaffeensis, E. platys, and E. risticii [ 1 µg of DNA from infected P388 cells]). The specific 495bp PCR product was not amplified from these targets. This observation is particularly important in relation to E. platys and E. equi, which are also associated with ehrlichiosis in dogs. 7 In this study, E. sennetsu and E. ewingii were not evaluated. However, less sequence homology exists at EC1 and EC2 annealing sites for these 2 species than for E. chaffeensis, a target that did not amplify the specific 495bp product (Fig. 5) . Therefore, it is unlikely that these templates would produce a detectable PCR product in this assay. A previous report demonstrated that E. canis could be detected using PCR. 9 However, the specificity of the PCR assay was not evaluated using genomic templates from other Ehrlichia species. In addition, a primer complementary to a universal bacterial 16S rRNA gene sequence was used in that PCR assay. A likely result would be nonspecific amplification of a wide variety of 16S rRNA genes.
Total nucleic acid was extracted from unfractionated blood for the PCR protocol described in this report. Extracting nucleic acid from unfractionated blood is less time consuming and tedious than isolation of leukocytes prior to extraction. Therefore, this method would be advantageous in clinical and research settings. This PCR/CH assay provided the sensitivity required for early or low-level detection without isolation of leukocytes from larger volumes of blood prior to the nucleic acid extraction.
These results indicated that the PCR/CH assay is more sensitive than CCI for detection of E. canis. Of the 9 dogs experimentally infected with E. canis, 3 did not develop ehrlichiosis and E. canis was not detected by PCR/CH or CCI. However, in all 6 dogs that developed ehrlichiosis, E. canis was isolated using CCI and PCR/CH. In 4 of these 6 dogs, E. canis was detected 7 days earlier by PCR/CH than with CCI. In a previous study in which PCR was used without CH for E. canis detection, CCI had increased sensitivity over PCR alone. 9 The increased sensitivity provided by the CH used in this report probably accounts for the earlier detection by PCR/CH compared with CCI ( Table 1 ). The validity of the PCR/CH results are otherwise confirmed by the consistent correlation with those obtained by CCI.
In conclusion, the results of this study indicated that the described PCR/CH assay is a reliable, rapid, sensitive, and specific method for detecting E. canis from unfractionated blood samples. The sensitivity of the PCR/CH assay exceeded that of CCI. CCI is laborious and expensive and requires 1-4 weeks for a definitive diagnosis. A definitive diagnosis of E. canis with PCR/ CH can be obtained within 2 days. Based on the results of this study, PCR/CH should be considered as an alternative or a complement to current diagnostic techniques.
